| Context-dependent signaling of CXC chemokine receptor 4 and atypical chemokine receptor 3 J Heuninck, CP Viciano, A Işbilir, B Caspar, D Capoferri, SJ Briddon, ... Molecular Pharmacology 96 (6), 778-793, 2019 | 35 | 2019 |
| Integrated biomarker analysis reveals L1CAM as a potential stratification marker for no specific molecular profile high-risk endometrial carcinoma A Ravaggi, D Capoferri, L Ardighieri, I Ghini, F Ferrari, C Romani, ... Cancers 14 (21), 5429, 2022 | 12 | 2022 |
| L1CAM expression as a predictor of platinum response in high‐risk endometrial carcinoma C Romani, D Capoferri, C Reijnen, S Lonardi, A Ravaggi, M Ratti, ... International Journal of Cancer 151 (4), 637-648, 2022 | 6 | 2022 |
| The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features C Romani, D Capoferri, E Grillo, M Silvestri, M Corsini, L Zanotti, ... Cancers 13 (4), 906, 2021 | 6 | 2021 |
| Pre-treatment Serum HE4 level as a novel independent prognostic biomarker for uterine cervical carcinoma patients E Bignotti, L Zanotti, P Todeschini, V Zizioli, C Romani, D Capoferri, ... Frontiers in Oncology 10, 584022, 2020 | 5 | 2020 |
| The pro-oncogenic sphingolipid-metabolizing enzyme β-galactosylceramidase modulates the proteomic landscape in BRAF (V600E)-mutated human melanoma cells D Capoferri, P Chiodelli, M Corli, M Belleri, E Scalvini, L Mignani, ... International Journal of Molecular Sciences 24 (13), 10555, 2023 | 4 | 2023 |
| Zebra-Sphinx: modeling sphingolipidoses in zebrafish L Mignani, J Guerra, M Corli, D Capoferri, M Presta International Journal of Molecular Sciences 24 (5), 4747, 2023 | 3 | 2023 |
| Finding the junction between claudins and endometrial carcinoma D Capoferri, E Bignotti, A Ravaggi, S Mitola, C Romani Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 189019, 2023 | 2 | 2023 |
| Ten Years of CRISPRing Cancers In Vitro D Capoferri, S Filiberti, J Faletti, C Tavani, R Ronca Cancers 14 (23), 5746, 2022 | 2 | 2022 |
| The D647N mutation of FGFR1 induces ligand-independent receptor activation M Domenichini, C Ravelli, M Corsini, S Codenotti, E Moreschi, A Gogna, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1867 (12), 130470, 2023 | 1 | 2023 |
| Dataset: Impact of β-Galactosylceramidase Overexpression on the Protein Profile of Braf (V600E) Mutated Melanoma Cells D Capoferri, P Chiodelli, S Calza, M Manfredi, M Presta Data 8 (12), 177, 2023 | 1 | 2023 |
| Impact of an irreversible β-galactosylceramidase inhibitor on the lipid profile of zebrafish embryos J Guerra, M Belleri, G Paiardi, C Tobia, D Capoferri, M Corli, E Scalvini, ... Computational and Structural Biotechnology Journal 23, 1397-1407, 2024 | | 2024 |
| Proteomic Analysis Highlights the Impact of the Sphingolipid Metabolizing Enzyme β-Galactosylceramidase on Mitochondrial Plasticity in Human Melanoma D Capoferri, L Mignani, M Manfredi, M Presta International Journal of Molecular Sciences 25 (5), 3062, 2024 | | 2024 |
| In vitro pharmacological characterisation of the role of ACKR3 on CXCR4-dependent and-independent function D Capoferri University of Glasgow, 2020 | | 2020 |
